Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

WHAT'S NEW

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Wednesday, Nov 16 2022

Full Issue

Perspectives: Congress Must Fund The Fight On Superbugs; FDA Needs To Act Quickly On The Adderall Shortage

Read recent commentaries about drug-cost issues.

USA Today: A Drug-Resistant Infection Killed My Daughter. It Was Preventable.

Drug-resistant infections, otherwise known as antimicrobial resistance or AMR, will kill more people worldwide this year than HIV or malaria. (Diane Shader Smith, 11/15)

Los Angeles Times: Don't Let Adderall Scarcity Trigger A Repeat Of The Opioid Epidemic 

U.S. pharmacies are critically low on Adderall and its generic equivalents, leaving more than 26 million patients scrambling and competing for the pills since late summer. The scarcity is going to last for many more months because of supply chain problems as well as federal restrictions on manufacturers and imports. (Leo Beletsky, 11/14)

Arizona Republic: AARP Was Wrong To Back Medicare Drug Price Control. It'll End Up Hurting Seniors

There’s no way to get around it: the newly enacted Inflation Reduction Act (IRA) marks a terrible blow to American seniors. For the millions of older Americans on Medicare, the future of medical innovation is much dimmer, as will be their access to critical prescription drugs. But AARP – the supposed bastion of senior advocacy – is apparently unfazed. It recently concluded a victory tour, which included an event in Arizona celebrating the bill’s enactment as a historic achievement for seniors. (Jon Decker, 11/14)

The New York Times: Democrats Just Held The Senate. Here’s What We Do Next. 

Voters rewarded Democrats for protecting the lives and livelihoods of struggling families in a pandemic; modernizing infrastructure, not just talking about it; allowing Medicare to negotiate lower drug prices; capping insulin costs for older Americans; making tax-dodging corporations pay up on billions in profit; lowering carbon emissions and reducing utility bills; and canceling student debt for over 40 million Americans. ... Democrats delivered a lot, but we can do more to make Americans’ lives better. (Sen. Elizabeth Warren, D-Mass., 11/12)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, May 6
  • Tuesday, May 5
  • Monday, May 4
  • Friday, May 1
  • Thursday, April 30
  • Wednesday, April 29
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF